Skip to main content
. Author manuscript; available in PMC: 2023 Dec 11.
Published in final edited form as: Am J Perinatol. 2022 May 12;41(Suppl 1):e156–e162. doi: 10.1055/a-1850-4429

Table 1.

Contraindications to dialysis initiation in neonates with ESKD reported among surveyed centers (n = 38 centers)

Contraindications reported in > 50% of surveyed centers Contraindications reported in 10–50% of surveyed centers Contraindications reported in < 10% of surveyed centers Contraindications reported in zero % of surveyed centers
  • Parent/guardian choosing not to pursue dialysis (N = 26; 68%)

  • Born below a minimum birth weight (n = 21; 55%)

  • Surgeon indicates contraindication for dialysis access placement (n = 21, 55%)

  • Severe pulmonary disorder/respiratory disease (n = 17; 47%)

  • Severe/life-threatening genetic abnormality (n = 13; 34%)

  • Severe neurologic impairment (n = 7; 18%)

  • Refractory hypotension (n = 7; 18%)

  • Severe/life-threatening cardiac abnormality (n = 7; 18%)

  • Severe/life-threatening liver abnormality (n = 3; 8%)

  • Below a minimum gestational age (n = 2; 5%)

  • Disagreement between nephrology and other services regarding the decision to initiate dialysis (n = 1; 3%)

  • Significant colorectal anomalies that would require creation of an ostomy

  • Presence of specific primary kidney disease (i.e., autosomal recessive polycystic kidney disease)

  • Presence of antenatal anuria/oliguria

  • Presence of social determinants of health inequities that would limit family’s ability to provide maintenance home dialysis therapy

Abbreviation: ESKD, end-stage kidney disease.